Multidrug-resistant Tuberculosis Detection, Latvia

Multidrug-resistant Tuberculosis Detection, Latvia

To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91% sensitivity and 96% specificity within 1 to 5 day...

Full description

Bibliographic Details
Main Authors: Girts Skenders, Alicia M. Fry, Inga Prokopovica, Silvija Greckoseja, Lonija Broka, Beverly Metchock, Timothy H. Holtz, Charles D. Wells, Vaira Leimane
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2005-09-01
Series:Emerging Infectious Diseases
Subjects:
TB/HIV control
developing countries
multidrug-resistant TB, tuberculosis, TB diagnosis, dispatch
Latvia
Online Access:https://wwwnc.cdc.gov/eid/article/11/9/04-1236_article

Internet

https://wwwnc.cdc.gov/eid/article/11/9/04-1236_article

Similar Items